In February, Tufts was downgraded by Fitch Ratings due to prolonged financial difficulties. The health system joins Portland, Ore.-based Legacy Health and Philadelphia-based Jefferson Health in selling off its lab assets as financial pressure builds.
The acquisition is expected to formally close in October. Tufts is aiming for a partnership with Labcorp to expand diagnostics and provide a single source option for patients and providers.
“Tufts Medicine’s long history of outstanding and innovative patient care will combine with Labcorp’s comprehensive expertise and resources to increase access to critical services in the diverse communities we proudly serve,” said Michael Dandorph, president and CEO of Tufts Medicine. “Our patients, physicians and workforce will remain at the center of all we do as we work closely with Labcorp to expand services in a way that delivers on our goal of a frictionless health care experience.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
